Home › Juvenile Myelomonocytic Leukemia › Pennsylvania › Philadelphia
Juvenile Myelomonocytic Leukemia clinical trials in Philadelphia, PA
4 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RecruitingPhase 1
- Children's Hospital of Philadelphia, Philadelphia
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · 25 mi away
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Recruiting
- Children's Hospital of Philadelphia, Philadelphia
Juvenile Myelomonocytic Leukemia trials in other cities
- Minneapolis, MN4 studies
- Boston, MA3 studies
- San Francisco, CA3 studies
- Indianapolis, IN3 studies
- Cincinnati, OH3 studies
- Atlanta, GA3 studies
- Washington, DC3 studies
- Memphis, TN3 studies
- Chicago, IL3 studies
- New York City, NY3 studies
- Ann Arbor, MI3 studies
- Seattle, WA3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.